TrialInternational journal of cancer2026

Neoadjuvant Atezolizumab and Chemotherapy for Non-Squamous Non-Small Cell Lung Cancer: Efficacy and Safety Results of an Open-Label, Single-Arm, Phase II Trial.

Benedikt Niedermaier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.